Could consolidate a little but has a priority review PDUFA date of 8/18/19 for Enrectinib solid tumors and ROSI-positive non-small cell lung cancer. Also PDUFA date of 9/2/19 for Tecentriq plus chemo
Earnings coming in August. Will it breakout to new highs?
